CADHERIN DYNAMICS AND GLAUCOMA
钙粘蛋白动力学和青光眼
基本信息
- 批准号:7015408
- 负责人:
- 金额:$ 36.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-02 至 2011-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Recent clinical trials demonstrate that significant, sustained intraocular pressure reduction in people with glaucoma slows or halts vision loss, even in patients with low-tension glaucoma. While the site of increased resistance in glaucoma is likely located in the conventional drainage pathway, the cellular mechanisms responsible for generation of this extra resistance are unknown. Previous work points to two possibilities that are not mutually exclusive: (i) abnormal accumulation and/or alterations in the extracellular matrix materials of the juxtacanalicular tissue; or (ii) alterations in the function of the intercellular junctions (and associated border pores) of the inner wall of Schlemm's canal. In the present application, we propose to study a family of cell-cell adhesion molecules, the cadherins, in the endothelial cells of Schlemm's canal. Cadherins form adherens junctional complexes, which are present in the conventional drainage pathway, but have only been described morphologically. Since homophilic protein- protein interactions of cadherin extracellular domains on adjacent cells are critical to the formation and maintenance of the integrity of at least three intercellular junctional complexes (including adherens, occludens and gap), and published evidence suggests that cell-cell adhesion plays a role in determining outflow resistance, we hypothesize that cadherins between Schlemm's canal endothelia strongly influence the generation of outflow resistance. Our study will examine cadherins at the molecular and functional levels and (i) specifically target cadherin-5 (plus associated catenin proteins) and disrupt adhesion between Schlemm's canal endothelia; (ii) analyze effects of pressure differences/stretch on relative expression levels, subcellular distribution and phosphorylation status of cadherin-5 plus associated catenins; and (iii) monitor signaling proteins that regulate the formation and remodeling of the cadherin-5 junction complex. Results obtained from these investigations will provide a basic understanding of the role of cadherin proteins in aqueous outflow resistance and uncover novel therapeutic targets for glaucoma therapy.
描述(由申请人提供):最近的临床试验表明,青光眼患者的显著持续眼内压降低可减缓或阻止视力丧失,即使是低眼压性青光眼患者也是如此。虽然青光眼中阻力增加的部位可能位于传统的引流途径中,但负责产生这种额外阻力的细胞机制尚不清楚。以前的工作指出了两种不相互排斥的可能性:(i)异常积累和/或改变的细胞外基质材料的小管组织;或(ii)改变的功能的细胞间连接(和相关的边界孔)的内壁Schlemm管。在本申请中,我们建议研究施累姆氏管内皮细胞中的细胞-细胞粘附分子家族,即钙粘蛋白。钙粘蛋白形成粘附连接复合物,其存在于传统的引流途径中,但仅在形态学上进行了描述。由于钙粘蛋白胞外结构域与相邻细胞之间的蛋白-蛋白相互作用对至少三种细胞间连接复合物的形成和维持至关重要,(包括粘附物、闭合物和间隙),并且已发表的证据表明细胞-细胞粘附在确定流出阻力中起作用,我们假设施莱姆管内皮细胞之间的钙粘蛋白强烈影响流出阻力的产生。我们的研究将在分子和功能水平上研究钙粘蛋白,(i)特异性靶向钙粘蛋白-5(ii)分析压力差/拉伸对钙粘蛋白-5加相关连环蛋白的相对表达水平、亚细胞分布和磷酸化状态的影响;和(iii)监测调节钙黏着蛋白-5连接复合物的形成和重塑的信号蛋白。从这些调查中获得的结果将提供一个基本的了解的作用,钙粘蛋白在水外流阻力,并发现新的治疗青光眼的治疗目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
W Daniel Stamer其他文献
W Daniel Stamer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('W Daniel Stamer', 18)}}的其他基金
"Concepts and Breakthroughs in Glaucoma" Conference
“青光眼的概念与突破”会议
- 批准号:
10317233 - 财政年份:2021
- 资助金额:
$ 36.19万 - 项目类别:
Basic Science Catalyzing Treatments for Glaucoma
青光眼的基础科学催化治疗
- 批准号:
9391815 - 财政年份:2017
- 资助金额:
$ 36.19万 - 项目类别:
相似国自然基金
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
- 批准号:82371054
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
TXNIP调控实验性青光眼视乳头星形胶质细胞的激活及其机制研究
- 批准号:82371048
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Mechanical Causation of Corneal Stromal Matrix Synthesis and Fibrosis
角膜基质基质合成和纤维化的机械原因
- 批准号:
10659976 - 财政年份:2023
- 资助金额:
$ 36.19万 - 项目类别:
Mechanisms of NMDAR contribution to traumatic injury in retinal ganglion cells
NMDAR对视网膜神经节细胞创伤性损伤的作用机制
- 批准号:
10570666 - 财政年份:2023
- 资助金额:
$ 36.19万 - 项目类别:
Elucidating signaling networks in Anterior Segment development, repair and diseases
阐明眼前节发育、修复和疾病中的信号网络
- 批准号:
10718122 - 财政年份:2023
- 资助金额:
$ 36.19万 - 项目类别:
The role of distal aqueous humor outflow tissue in glucocorticoid-induced glaucoma
远端房水流出组织在糖皮质激素诱发青光眼中的作用
- 批准号:
10667863 - 财政年份:2023
- 资助金额:
$ 36.19万 - 项目类别:
The impact of age-related vitreous degeneration and vitreous replacement on scleral biomechanics: a novel mechanism and treatment target for glaucoma
年龄相关性玻璃体变性和玻璃体置换对巩膜生物力学的影响:青光眼的新机制和治疗目标
- 批准号:
10647522 - 财政年份:2023
- 资助金额:
$ 36.19万 - 项目类别:
Spatiotemporal visualization of adenylyl cyclase signaling
腺苷酸环化酶信号传导的时空可视化
- 批准号:
10664707 - 财政年份:2023
- 资助金额:
$ 36.19万 - 项目类别:
PAGE-G: Precision Approach combining Genes and Environment in Glaucoma
PAGE-G:青光眼基因与环境相结合的精准方法
- 批准号:
10797646 - 财政年份:2023
- 资助金额:
$ 36.19万 - 项目类别:
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 36.19万 - 项目类别:














{{item.name}}会员




